$ISRG following our Consumption Cliff theme. #ACA attrition is only a part of the issue, though.
View original →$ISRG following our Consumption Cliff theme. #ACA attrition is only a part of the issue, though.
View original →We are presenting $HCA short at 12:30PM today. Quad Factor headwinds, Signal Strength Short, Fundamental downside 2Q26, secular headwinds 2026 and 2027. @Hedgeye @KeithMcCullough https://t.co/RMSHMyUTPw
View original →$TXG working better than expected while price target changes play cautious catch up after the move. Is the rally 22% short interest as a factor? #AI labs? NIH adoption of Spatial ramping? Quad Factor Score? https://t.co/Gue5w40X3Q
View original →$LLY $NVO #GLP1 $XLV Medicare Bridge program gathering momentum into July 1 launch. Weight loss drugs for $50 a month likely transforms healthcare. https://t.co/hl86AUO76V
View original →$LLY $NVO #GLP1 $XLV Medicare Bridge program gathering momentum into July 1 launch. Weight loss drugs for $50 a month likely transforms healthcare. https://t.co/hl86AUO76V
View original →$LLY $NVO #GLP1 $XLV Medicare Bridge program gathering momentum into July 1 launch. Weight loss drugs for $50 a month likely transforms healthcare. https://t.co/hl86AUO76V
View original →Quad 4 is the most aligned Quad Factor Score regime on a trailing 1W basis. This is new and a handoff from Quad 2/3 over the trailing 1M. I am putting the highest/lowest ranked names for Quad 4 in The Call Out note this morning. @KeithMcCullough @Hedgeye https://t.co/MADQFV4Wjv
View original →Staying short $THC "down here" & into 2Q26. 1) $THC factor set up hates Quad 2, 3 and 4 with Quad 4 deflation most likely. 2) HC trading not yet aligned with Quad 4, but improving. 3) #ACA enrollment accelerated to the downside in May (grace period ended in April) and HC Macro for surgical centers deteriorated. @Hedgeye @KeithMcCullough
View original →We are presenting $RMD short today at 10AM. OSA at the top of the list when we measured #GLP1 and the consequence of mass market weight loss. @HedgeyeHealth @Hedgeye @KeithMcCullough
View original →The big advantage we have on $HCA isn't just solid fundamental research. Quad Factor Scoring, which is new and proprietary, tells us if the market will care and Signal Strength provides timing and conviction. The overlap is a powerful. @KeithMcCullough @Hedgeye https://t.co/pVjSHDReHG https://t.co/1j5zhE1YKS
View original →